All stock lists
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$10.64+$0.02 (+0.19%)
Market cap
$898M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 23, 2016
Website
Insider Score
82/ 100
CRVS Insider Score
Bullish4 qualifying trades · 1 insider · $50.48K bought in the last 90 days
CRVS Stock Insider Trading Activity
CRVS stock’s insider trading shows 4 purchases for an estimated $50.48K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days4 qualifying buys1 insider$50.48K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
Filters
| Form 4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Arcara Jeffrey Other | Buy | 503 | $10.37 | $5.22K | 14.4% | 4,000 | Nov 13, 2026 | CExec BuyDilution | Form 4 |
| Arcara Jeffrey Other | Buy | 500 | $10.71 | $5.35K | 12.5% | 4,500 | Nov 13, 2026 | CExec BuyDilution | Form 4 |
| Arcara Jeffrey Other | Buy | 497 | $11.12 | $5.52K | 16.6% | 3,497 | Nov 12, 2026 | CExec BuyDilution | Form 4 |
| Arcara Jeffrey Other | Buy | 3,000 | $11.46 | $34.38K | New | 3,000 | Nov 11, 2026 | AFirst BuyExec BuyDilution | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.